Arrhythmia, Ventricular
8
4
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Loop Recorder Implantation in Patients With Mitral Annular Disjunction
Adding Lidocaine to Custodiol Mixture
Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure
Different Reperfusion Timing and Ventricular Arrhythmias in STEMI Patients
MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients